Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Summit Therapeutics PLC (SMMT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Summit Therapeutics PLC's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.855 +0.305    +8.59%
13:24:40 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 427,087
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 3.520 - 3.870
Summit Therapeutics PLC 3.855 +0.305 +8.59%

Summit Therapeutics PLC Company Profile

 
Get an in-depth profile of Summit Therapeutics PLC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

105

Equity Type

ADR

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company’s lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab. The company was founded in 2003 and is headquartered in Miami, Florida.

Contact Information

Address 601 Brickell Key Drive Suite 1000
Miami, 33131
United States
Phone 650 460 8308
Fax -

Top Executives

Name Age Since Title
Francesco Muntoni - - Member of Scientific Advisory Board
Edith Sim - - Member of Scientific Advisory board
Bob Sim - - Member of Scientific Advisory board
Roger Patient - - Member of Scientific Advisory Board
Derek Stemple - - Member of Scientific Advisory board
William Graham Richards 84 - Member of Scientific Advisory board
Jean-Paul Vincent - - Member of Scientific Advisory board
Marcel van den Heuvel - - Member of Scientific Advisory Board
Ujwala Mahatme 58 2020 Independent Non-Executive Director
Yu Xia 56 2023 Director
Mahkam Zanganeh 54 2020 Co-CEO, President & Director
Robert W. Duggan 79 2019 Co-CEO & Executive Chairman
Kenneth A. Clark 65 2021 Lead Independent Director
Robert F. G. Booth 70 2022 Independent Director
Alessandra Cesano 63 2022 Independent Non-Executive Director
Dame Kay Davies 73 - Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor
Manmeet Singh Soni 46 2019 COO, CFO & Director
Mostafa Ronaghi 55 2024 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SMMT Comments

Write your thoughts about Summit Therapeutics PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
László Rádi
László Rádi Mar 17, 2023 6:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This seems promising
Nhat Doan
Nhat Doan Dec 15, 2022 3:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
∆ SYMBOLS that can not be SHORT Must not BUY and DELETE Forever. 🤗🤩👍👹💣∆
travis hutchinson
travis hutchinson Mar 17, 2021 9:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Summit on the way up!
MoneyManager MoneyManager
Money2Manage4U Nov 12, 2020 4:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what happens here ? anybody ? somebody knows ? what is this rocket ?
Daniel Santamaria Rubio
Daniel Santamaria Rubio Mar 20, 2020 10:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
interesting progress they are making in the field of vaccines.. keep the good job.
Adrian Resendiz
Adrian Resendiz Mar 15, 2020 6:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this will be a very interesting to look at when the market opens.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email